Vimarsana
Biggest News Aggregation in the World

Page 28 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sera Prognostics Today - Breaking & Trending Today

Preeclampsia Drugs Market 2021 Briefing, Trends, Applications, Types, Research, Forecast To 2028 – KSU - Vimarsana News

Preeclampsia Drugs Market 2021 Briefing, Trends, Applications, Types, Research, Forecast To 2028 – KSU

Quality insights about the market research are delivered via an outstanding Preeclampsia Drugs Market report by keeping in mind the way people live, b

Sera Prognostics Completes $100M Series E Financing - Vimarsana News

Sera Prognostics Completes $100M Series E Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Halma sets sights on perinatal and prenatal health space with PeriGen acquisition - Vimarsana News

Halma sets sights on perinatal and prenatal health space with PeriGen acquisition

Photo by Ariel Skelley/Getty Images Halma, a UK-based health tech company, snapped up perinatal and prenatal health AI company PeriGen for $58 million earlier this week. Founded in 2000, PeriGen makes software products focused on the childbirth process that give clinicians more patient data based on algorithms and analysis. Its Early Warning System and Clinical Decision Support tool is able to use artificial intelligence to monitor patients in labor and find any potential issues that need to be addressed in a timely manner. The tool was designed to help clinicians interpret complex data. It ...

Four Biotechs Rake in Over $350 Million for Rare Diseases, Cancers and More - Vimarsana News

Four Biotechs Rake in Over $350 Million for Rare Diseases, Cancers and More

Published: Apr 29, 2021 By Alex Keown Less than one year after  launching, Ohio-based Forge Biologics  secured $120 million in a Series B financing round to support the clinical development of its gene therapy program for rare diseases, including the typically fatal Krabbe disease. In an announcement this morning, Forge said the proceeds from the Series B program will be used to accelerate the expansion of its AAV manufacturing CDMO capabilities with cGMP production capacity and operate its subsidiaries that are advancing novel AAV gene therapy programs. The company said it takes ...

Preterm Birth Diagnostic Test Kits Market 2021: Global Trends, Growth Analysis, Opportunities and Fo - Vimarsana News

Preterm Birth Diagnostic Test Kits Market 2021: Global Trends, Growth Analysis, Opportunities and Fo

Search jobs 05-Apr-2021 Preterm Birth Diagnostic Test Kits Market 2021: Global Trends, Growth Analysis, Opportunities and Forecast Report to 2028 | Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products | FMI Report A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028’, has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the lon...